Orbital Therapeutics
Business Services · Massachusetts, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
100 Binney St Fl 4, Cambridge, Massachus...Website
www.orbitaltx.comRevenue
$8.5 MillionIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
2
2
2
1
1
1
About Orbital Therapeutics
Orbital Therapeutics is a biotechnology company that develops advanced RNA-based medicines designed to reprogram cells and treat diseases at their source. The company uses integrated RNA technologies and targeted delivery systems to create precise, programmable therapies for conditions such as autoimmune diseases, cancer, and other serious illnesses.Explore more
Orbital Therapeutics Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Orbital Therapeutics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Website visits: Recent activity has been detected on your website
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Click to see if Orbital Therapeutics had a recent Job posting/layoffs
Product Launch: Get notified when Orbital Therapeutics launches new products
Check if Orbital Therapeutics has recently received funding, and reach out quickly before it becomes old news!
Earning: See what the market has to say on Orbital Therapeutics recently announced quarterly report
Congratulate Masked Content for being promoted to Masked Content at Orbital Therapeutics
Check out if Orbital Therapeutics is spiking on competitors!
Funding: Get notified immidiatlly once Orbital Therapeutics has new funding data
Orbital Therapeutics, which may be a good buyer, showed buying intent in Masked Content Topic
Recommended Actions
Find VP level buyers at Orbital Therapeutics
Find 3 more new buyers
Compare Similar Companies to Orbital Therapeutics
Compare insights from companies similar to Orbital Therapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Orbital Therapeutics is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Orbital Therapeutics is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Orbital Therapeutics.
Orbital Therapeutics financials insights
Gather financial insights about Orbital Therapeutics, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2023
Series A
$270M
Orbital Therapeutics Tech Stack
A closer look at the technologies used by Orbital Therapeutics
Most Recent Scoops
Person-Based
Left Company
Executive Move
Executive Moves, Left Company
Left Company
Executive Move
Executive Moves, Left Company
Mergers & Acquisitions (M&A)
Mergers & Acquisitions, Acquisitions, Mergers
New Hire
Executive Move
Executive Moves, New Hire
Orbital Therapeutics News & Media
Orbital Therapeutics Appoints Geno Germano, Biopharma Veteran, to its Board of Directors
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Orbital Therapeutics, a company dedicated to enhancing global health by unleashing the full potential of RNA medicines, today announced the appointment of Geno Germano to its Board of Directors. Mr. Germano is a 35-year biopharma and life sciences industry veteran with extensive development and commercialization senior leadership experience across multiple therapeutic areas. “We are excited to welcome Geno to Orbital and will benefit from his deep expertise inOrbital Therapeutics Appoints Anna Dixon as Senior Vice President, Human Resources
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Orbital Therapeutics has announced the appointment of Anna Dixon as senior vice president (SVP), human resources.Orbital Therapeutics Appoints Veteran Biopharma Leader, Ron Philip, as Chief Executive Officer
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Orbital Therapeutics today announced the appointment of Ron Philip as chief executive officer (CEO) and a member of its board of directors.
Read more news
Top Business Services Companies
Top companies in Australia by revenue
Frequently Asked Questions Regarding Orbital Therapeutics
Sign Up For FreeTo access detailed company insights
Orbital Therapeutics is a biotechnology company that develops advanced RNA-based medicines designed to reprogram cells and treat diseases at their source. The company uses integrated RNA technologies and targeted delivery systems to create precise, programmable therapies for conditions such as autoimmune diseases, cancer, and other serious illnesse... Read More
